Top

Published in:

Open Access 01-04-2018 | Original Paper

PRES in the course of hemato-oncological treatment in children

Authors: Katarzyna Musioł, Sylwia Waz, Michał Boroń, Magdalena Kwiatek, Magdalena Machnikowska-Sokołowska, Katarzyna Gruszczyńska, Grażyna Sobol-Milejska

Published in: Child's Nervous System | Issue 4/2018

Abstract

Introduction

Posterior reversible leukoencephalopathy syndrome (PRES) is a clinical syndrome of varying aetiologies, characterised by acute neurological symptoms of brain dysfunction with MRI abnormalities in posterior cerebral white and grey matter. In most cases, symptoms resolve without neurological consequences.

Aim

The aim of this paper is the analysis of predisposing factors, clinical outcomes and radiological features of PRES in eight children with hemato-oncological disease.

Material and methods

We analysed the medical records of eight hemato-oncological patients aged from 3.0 to 16.1 years. The mean of age at primary diagnosis was 8.5 years.

Results

All patients had both clinical and radiological PRES features. Seven out of eight underwent intensive chemotherapy regimens. Time elapsed from start of treatment to the occurrence of PRES ranged from 6 to 556 days. In one case, PRES occurred before chemotherapy and was the first symptom of cancer. Most (six of eight) patients had history of hypertension (> 95pc) and some (two of eight) occurred electrolyte imbalance—mainly hypomagnesaemia. Patients presented headache (seven of eight), disturbances of consciousness (six of eight), seizures (six of eight), visual changes (four of eight) and vomiting (three of eight). MRI demonstrated abnormalities in seven children: typical cerebral oedema in the white matter of the occipital to the parietal lobes. Most patient lesions in the MRI shrunk after 4 weeks, and clinical symptoms of PRES disappeared completely within a few hours to few days.

Conclusion

PRES may complicate oncological treatment in children. Hypertension is the most important risk factor of PRES. PRES should be included in differential diagnosis in all patients with acute neurological symptoms.

Khan RB, Sadighi ZS, Zabrowski J, Gajjar A, Jeha S (2016) Imaging patterns and outcome of posterior reversible encephalopathy syndrome during childhood cancer treatment. Pediatr Blood Cancer 63(3):523–526. https://doi.org/10.1002/pbc.25790 CrossRefPubMed

Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65(2):205–210.

Roth C, Ferbert A (2011) The posterior reversible encephalopathy syndrome: what’s certain, what’s new? Pract Neurol 11:136–144CrossRefPubMed

Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500CrossRefPubMed

Lamy C, Oppenheim C, Méder JF, Mas JL (2004) Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14:89–96CrossRefPubMed

Lucchini G, Grioni D, Colombini A, Contri M, De Grandi C, Rovelli A, Conter V, Masera G, Jankovic M (2008) Encephalopathy Syndrome in children with hemato-oncological disorders is not always posterior and reversible. Pediatr Blood Cancer 51:629–633CrossRefPubMed

Legriel S, Pico F, Azoulay E (2011) Annual Update in Intensive Care and Emergency Medicine 2011. Understanding posterior reversible encephalopathy syndrome. Springer-Verlag, Berlin Heidelberg, pp 631–359. https://doi.org/10.1007/978–3–642-18,081-1 CrossRef

Siebert E, Bohner G, Endres M, Liman TG (2014) Clinical and radiological spectrum of posterior reversible encephalopathy syndrome: does age make a difference? – A retrospective comparison between adult and pediatric patients. PLoS One 9(12):e115073CrossRefPubMedPubMedCentral

Cordelli DM, Masetti R, Bernardi B, Barcia G, Gentile V, Biagi C, Prete A, Pession A, Franzoni E. Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2012 ; 58(5):785–90

10.

Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29:1043–1049CrossRefPubMed

11.

Arzanian MT, BSh S, Karimzadeh P, Kajiyazdi M, Malek F, Hammoud M (2014 Spring) Posterior reversible encephalopathy syndrome in pediatric hematologic-oncologic disease: literature review and case presentation. Iran J Child Neurol 8(2):1–10PubMedPubMedCentral

12.

Gümüş H, Per H, Kumandaş S, Yikilmaz A (2010) Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature. Neurol Sci 31(2):125–131. https://doi.org/10.1007/s10072-009-0158-z. Epub 2009 Oct. CrossRefPubMed

13.

Girişgen I, Tosun A, Sönmez F, Ozsunar Y (2010) Recurrent and atypical posterior reversible encephalopathy syndrome in a child with peritoneal dialysis. Turk J Pediatr 52(4):416–419PubMed

14.

Morris EB, Laningham FH, Sandlund JT, Khan RB (2007) Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 48:152–159CrossRefPubMed

15.

Gupta A, Swaroop C, Rastogi R, Garg R, Bakhshi S (2008) Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy. Pediatr Hematol Oncol 25:351–358CrossRefPubMed

16.

Kim SJ, Im SA, Lee JW, Chung NG, Cho B, Kim HK, Lee IG (2012) Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia. Pediatr Neurol 47(6):436–442CrossRefPubMed

17.

Endo A, Fuchigami T, Hasegawa M, Hashimoto K, Fujita Y, Inamo Y, Mugishima H. Posterior reversible encephalopathy syndrome in childhood: report of four cases and review of the literature. Pediatr Emerg Care. 2012; 28(2):153–7.

18.

de Laat P, te Winkel ML, Devos AS, Catsman-Berrevoets CE, Pieters R, van den Heuvel-Eibrink MM (2011) Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol 22:472–478CrossRefPubMed

19.

Belaramani KM, Lai V, Li CH, Lee AC, Kwong NS (2011) Reversible posterior leukoencephalopathy syndrome in Chinese children induced by chemotherapy: a review of five cases. Hong Kong Med J 17(1):61–66PubMed

20.

Won SC, Kwon SY, Han JW, Choi SY, Lyu CJ (2009) Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. J Pediatr Hematol Oncol 31(7):505–508. https://doi.org/10.1097/MPH.0b013e3181a71868 CrossRefPubMed

21.

D’Angelo P, Farruggia P, Lo Bello A, Trizzino A, Tropia S, Caselli D, Aricò M (2006) Reversible posterior leukoencephalopathy syndrome: report of 2 simultaneous cases in children. J Pediatr Hematol Oncol 28(3):177–181CrossRefPubMed

22.

Bakshi R, Bates VE, Mechtler LL, Kinkel PR, Kinkel WR (1998) Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia 39(3):295–299CrossRefPubMed

23.

Yamada A, Ueda N (2012) Age and gender may affect posterior reversible encephalopathy syndrome in renal disease. Pediatr Nephrol 27:277–283CrossRefPubMed

24.

Raj S, Overby P, Erdfarb A, Ushay HM (2013) Posterior reversible encephalopathy syndrome: incidence and associated factors in a pediatric critical care population. Pediatr Neurol 49:335–339CrossRefPubMed

25.

Wan Jamaludin WF, Mohd Zaki F, Tumian NR, Wong CL, Abdul Wahid SF (2011) Posterior reversible encephalopathy syndrome as the initial presentation of acute lymphoblastic leukaemia. Journal of Hematological Malignancies 1(1)

26.

McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS et al (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189:904–912CrossRefPubMed

27.

Ni J, Zhou LX, Hao HL, Liu Q, Yao M, Li ML, Peng B, MD, Cui LY. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: a retrospective series of 24 patients. J Neuroimaging 2011;21:219–224

28.

Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21:1199–1206PubMed

29.

Chaudhary N, Majeed R, Borker A (2011) Isolated cerebellar involvement in posterior reversible encephalopathy syndrome in a child with acute lymphoblastic leukemia. Indian J Med Paediatr Oncol 32(4):211–213. https://doi.org/10.4103/0971–5851.95143 CrossRefPubMedPubMedCentral

30.

Donmez FY, Guleryuz P, Agildere M (2014) MRI findings in childhood PRES: what is different than the adults? Clin Neuroradiol

31.

Tambasco N, Mastrodicasa E, Salvatori C, Mancini G, Romoli M, Caniglia M, Calabresi P, Verrotti A (2016) Prognostic factors in children with PRES and hematologic diseases. Acta Neurol Scand 134(6):474–483. https://doi.org/10.1111/ane.12570 CrossRefPubMed

32.

Norman JK, Parke JT, Wilson DA, McNall-Knapp RY (2007) Reversible posterior leukoencephalopathy syndrome in children undergoing induction therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 49:198–203. https://doi.org/10.1002/pbc.20597 CrossRefPubMed

33.

Hualde Olascoaga J, Molins Castiella T, Souto Hernández S, Becerril Moreno F, Yoldi Petri ME, Sagaseta de Ilurdoz M, Molina Garicano J. Reversible posterior leukoencephalopathy: report of two cases after vincristine treatment. An Pediatr (Barc) 2008; 68(3):282–5

34.

Kwon EJ, Kim SW, Kim KK, Seo HS, Kim DY. A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome. Cancer Res Treat 2009; 41(1):53–55. doi: https://doi.org/10.4143/crt.2009.41.1.53. Epub 2009 Mar 31

35.

How J, Blattner M, Fowler S, Wang-Gillam A, Schindler SE (2016) Chemotherapy-associated posterior reversible encephalopathy syndrome: a case report and review of the literature. Neurologist 21(6):112–117CrossRefPubMed

36.

Vieillot S, Pouessel D, de Champfleur NM, Becht C, Culine S (2007) Reversible posterior leukoencephalopathy syndrome after carboplatin therapy. Ann Oncol 18(3):608–609CrossRefPubMed

37.

Saito B, Nakamaki T, Nakashima H, Usui T, Hattori N, Kawakami K, Tomoyasu S (2007) Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia. Am J Hematol 82(4):304–306CrossRefPubMed

Title: PRES in the course of hemato-oncological treatment in children
Authors: Katarzyna Musioł
Sylwia Waz
Michał Boroń
Magdalena Kwiatek
Magdalena Machnikowska-Sokołowska
Katarzyna Gruszczyńska
Grażyna Sobol-Milejska
Publication date: 01-04-2018
Publisher: Springer Berlin Heidelberg
Published in: Child's Nervous System / Issue 4/2018
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI: https://doi.org/10.1007/s00381-017-3664-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

PRES in the course of hemato-oncological treatment in children

Abstract

Introduction

Aim

Material and methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Aim

Material and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2018

Wester Knut (editor): Arachnoid Cysts

Management of idiopathic spinal epidural lipomatosis: a case report and review of the literature

Unique combination of myxopapillary ependymoma and conus lipoma with subcutaneous extension in an 11-month-old child

Disseminated juvenile xanthogranuloma occurring after treatment of Langerhans cell histiocytosis: a case report

Congenital lumbar kyphosis with skin ulceration and osteomyelitis in a myelomeningocele child: a case report

Congenital obstruction of foramen of Monro: report of 10 patients and literature review